Cardinal Health Buys Chinese Drug Importer For $470M

Law360, New York (November 29, 2010, 7:07 PM EST) -- Cardinal Health has acquired Zuellig Pharma China, the country's largest pharmaceutical importer, in a $470 million deal that will gain the health care services giant a foothold in one of the fastest-growing global markets.

The acquisition of the privately owned Zuellig Pharma, known locally as Yong Yu, was the second acquisition this month for the Dublin, Ohio-based Cardinal Health, which had picked up privately held pharmaceutical distributor Kinray, Inc. for $1.3 billion.

“The acquisition of Yong Yu follows an extensive evaluation of opportunities to drive growth in targeted geographies...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.